Cyclerion Therapeutics Ownership | Who Owns Cyclerion Therapeutics?
Cyclerion Therapeutics Ownership Summary
Cyclerion Therapeutics is owned by 14.61% institutional investors, 32.73% insiders, and 52.66% retail investors. Zrc wealth management is the largest institutional shareholder, holding 0% of CYCN shares. Fidelity Select Biotechnology is the top mutual fund, with 1.52% of its assets in Cyclerion Therapeutics shares.
CYCN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Cyclerion Therapeutics | 14.61% | 32.73% | 52.66% |
Sector | Healthcare Stocks | 279.15% | 10.63% | -189.78% |
Industry | Biotech Stocks | 63.94% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Zrc wealth management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Zrc wealth management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Zrc wealth management | - | - | -20.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Zrc wealth management | - | - | -20.00 |
Sold Out
Holder | Change |
---|---|
Zrc wealth management | -20.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 18 | - | 373,392 | -2.24% | 14 | 6.49% | 3 | -57.14% | 2 | -33.33% |
Dec 31, 2024 | 18 | 20.00% | 381,943 | -63.37% | 15 | 0.88% | 7 | 133.33% | 3 | -25.00% |
Sep 30, 2024 | 15 | -11.76% | 1,042,639 | -0.86% | 41 | 2.35% | 3 | -57.14% | 4 | 100.00% |
Jun 30, 2024 | 17 | 13.33% | 1,051,710 | -1.73% | 41 | 2.28% | 7 | 40.00% | 2 | - |
Mar 31, 2024 | 15 | -6.25% | 1,070,254 | 0.07% | 42 | 2.30% | 5 | - | 2 | -66.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Select Biotechnology | 38.31K | 1.52% | -3.55K |
Fidelity Growth Compy Commingled Pl O | 29.17K | 1.16% | - |
Fidelity Growth Compy Commingled Pl S | 29.68K | 1.10% | 298.00 |
Vanguard Institutional Extnd Mkt Idx Tr | 23.49K | 0.77% | - |
Fidelity Growth Company Fund | 20.56K | 0.76% | - |
LUX IM Global Medtech HX | 16.43K | 0.46% | - |
Fidelity Nasdaq Composite ETF | 13.17K | 0.37% | - |
Fidelity Growth Company K6 | 9.22K | 0.34% | -298.00 |
Fidelity Extended Market Index | 11.18K | 0.31% | - |
BlackRock Extended Equity Market K | 3.00K | 0.12% | -1.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 21, 2024 | Slate Path Capital LP | - | Sell | $555.11K |
Aug 09, 2023 | MCGUIRE TERRANCE | - | Sell | $27.16 |
Jun 03, 2021 | MCGUIRE TERRANCE | - | Buy | $289.63K |
Jun 03, 2021 | MCGUIRE TERRANCE | - | Buy | $10.36K |
Jun 03, 2021 | MCGUIRE TERRANCE | - | Buy | $10.36K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | - | 1 |
2024 Q3 | - | - |
2024 Q1 | - | - |
2023 Q4 | - | - |
CYCN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools